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The biological functions of microRNAs (miRNAs) have been studied in a number of eukary-
otic species. Recent studies on vertebrate animals have demonstrated critical roles of 
miRNA in immune and metabolic activities. However, studies on the functions of miRNA 
in invertebrates are very limited. Here, we demonstrated that miR-31 from Apostichopus 
japonicus disrupts the balance of lipid metabolism, thus resulting in cell apoptosis by 
targeting complement C1q tumor necrosis factor-related protein 9 (AjCTRP9), a novel 
adipokine with pleiotropic functions in immunity and metabolism. Lipidomic analysis 
suggested that the intercellular lipid metabolites were markedly altered, and three cer-
amide (Cer) species synchronously increased in the AjCTRP9-silenced coelomocytes. 
Moreover, exogenous Cer exposure significantly induced apoptosis in the coelomocytes 
in vivo, in agreement with findings from miR-31 mimic- or AjCTRP9 small-interfering RNA-
transfected coelomocytes. Furthermore, we found that the imbalance in sphingolipid 
metabolism triggered by the overproduction of Cers ultimately resulted in the activation 
of the apoptosis initiator caspase-8 and executioner caspase-3. Our findings provide 
the first direct evidence that miR-31 negatively modulates the expression of AjCTRP9 
and disturbance of Cer channels, thus leading to caspase-3- and caspase-8-dependent 
apoptosis, during the interactions between pathogens and host.
Keywords: Apostichopus japonicus, mir-31, complement c1q tumor necrosis factor-related protein 9, lipidomics, 
ceramide, apoptosis
inTrODUcTiOn
After the invasion of pathogens, the innate immune response reacts immediately as the first barrier 
to defend the host. Various cellular and humoral defense pathways are simultaneously activated 
through different signaling networks. Efforts have been made to identify the roles of immune-related 
molecules during immune responses. However, studies on the regulatory networks of these molecules 
and their interactions in host defense processes are lacking. Emerging studies deciphering the vari-
ous cellular and signaling networks linking the immune defense with metabolism have contributed 
to the understanding of disease pathogenesis and the development of therapeutic strategies (1). It is 
therefore no surprise that the dissection of the interface connecting the immune system to metabolic 
pathways including glycolysis, lipid, and amino acid metabolism has recently gained interest (2, 3). 
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This metabolic regulation is largely controlled by extracellular 
signals that direct the uptake, storage, and utilization of sub-
strates (glucose, amino acids, and fatty acids) under immune 
responses. Among them, lipid metabolism has been shown to 
be closely related to the immune response, because the lipids of 
the membrane bilayer form the first line of barrier between a cell 
and its environment (4), and lipid metabolism generates a variety 
of bioactive signaling molecules, including phosphatidic acid, 
triacylglycerol (TAG), sphingosine, and ceramide (Cer), which 
participate in the regulation of many cellular processes such as 
cell growth, membrane homeostasis, inflammation, and apop-
tosis (5). Imbalances in cellular lipid metabolism increase the 
susceptibility of the host to pathogenic invasions and ultimately 
lead to cell death in the host (6, 7). Therefore, the regulation of 
lipid metabolism may also change the host immune response to 
pathogenic challenge. Manipulation of lipid metabolism path-
ways may contribute to the enhancement of host immune systems 
against pathogens.
microRNAs (miRNAs) are highly conserved small non-coding 
RNAs (~22 nucleotides) that regulate gene expression primarily 
by binding to the 3’-untranslated regions of target mRNAs, thus 
decreasing target protein synthesis and sometimes resulting in 
mRNA degradation (8, 9). As one of the most abundant classes 
of gene regulators, miRNAs are involved in many biological pro-
cesses, such as cell proliferation (10), tumorigenesis (11), apop-
tosis (12), and inflammation (13). Recent studies have indicated 
that miRNAs also play novel roles in regulating metabolic path-
ways through the control of target genes involved in metabolic 
processes (14, 15), and especially in controlling lipid metabolic 
homeostasis and host inflammatory responses in cardiovascular 
diseases (16, 17).
To date, more than 30 miRNAs have been identified to play 
crucial roles in the regulation of lipid metabolism through various 
pathways, such as fatty acid oxidation, and biosynthesis of fatty 
acids, cholesterol, and TAG (5, 18, 19). The first evidence linking 
specific miRNAs to critical pathways in lipid metabolism has been 
found in the fruit fly Drosophila melanogaster, thus indicating 
that dme-miR-14 regulates lipid metabolism by downregulation 
of the production of TAG and diacylglycerol (20). Later, another 
miRNA, miR-33, which has two isoforms (miR-33a and miR-
33b) and is highly conserved across species, was identified from 
a number of cell types including macrophages, hepatocytes, and 
endothelial cells (21). The overexpression of miR-33a/b decreases 
both fatty acid β-oxidation and insulin signaling in radioactively 
labeled hepatic cell lines, whereas the inhibition of endogenous 
miR-33a/b increases these two metabolic pathways, thereby 
suggesting that miR-33 plays important roles in regulating lipid 
homeostasis in concert with the host genes (22). Moreover, a 
study by Ouimet et  al. has revealed that macrophage-specific 
miR-33 deletion increases oxidative respiration and decreases 
atherosclerosis progression by promoting the M2 macrophage 
polarization-associated gene profile, thus suggesting that silenc-
ing miR-33 may be an effective therapeutic approach in the 
treatment of chronic inflammatory diseases (17).
Multiple miRNAs may also share the same target mRNA in 
the regulating lipid metabolism. Both miR-370 and miR-122 
directly target the transcription factor sterol regulatory element 
binding protein 1c in Hep2G cells, thereby regulating fatty acid 
and triglyceride biosynthesis (23). Other miRNAs, such as miR-
130 and miR-335, are also important players in the regulation of 
lipid metabolism (24, 25). Although connections between lipid 
metabolism and the host inflammatory responses through miRNA 
have been studied (26), the molecular mechanisms of how the 
miRNAs modulate lipid metabolism in response to pathogenic 
diseases remain unclear. Systemic studies on the network of lipid 
metabolism and host defenses in cells are still needed.
The invertebrate sea cucumber, Apostichopus japonicus 
(Echinodermata, Holothuroidea), has an innate immune sys-
tem and is one of the most important marine economic species 
in the Chinese aquaculture. Unfortunately, the natural sources 
of A. japonicus in China have declined drastically, owing to 
outbreaks of various viral and bacterial diseases (27). Among 
these diseases, skin ulceration syndrome (SUS) causes high 
infectious and lethal rates and has received substantial atten-
tion (27, 28). In our previous work, we have found that miR-31 
and miR-2008 expression levels are markedly increased in 
sea cucumbers with SUS by high-throughput analyses, thus 
indicating that these molecules play crucial roles in this host–
pathogen interaction (29). Our other work has also demon-
strated that the samples with SUS exhibit significant metabolic 
differences compared with the metabolic profiles from healthy 
A. japonicus (30). Undoubtedly, miRNAs might play essential 
roles in mediating the innate immunity and metabolic path-
ways in the sea cucumbers with SUS. The connection between 
miRNAs and the innate immune response is largely unknown 
to the best of our knowledge, especially in non-model organ-
isms such as the sea cucumber. The present study aimed at 
exploring the potential of regulation of the complement c1q 
tumor necrosis factor-related protein 9 gene (AjCTRP9), a 
novel adipocyte-derived cytokine, by miR-31. CTRP9 is an 
adipokine that has pleiotropic functions in immunity and 
metabolism (31, 32) and was selected as a promising target for 
functional validation. Our results clearly demonstrated that 
miR-31, a multifunctional regulatory molecule, negatively 
modulates the expression of AjCTRP9 and induces cell apopto-
sis by disturbing the lipid metabolism balance, thus resulting in 
the overproduction of Cers. The findings of the current study 
provide new insights into the mechanisms of pathogenesis 
of infectious diseases in A. japonicus from the perspective of 
miRNA-mediated cross-talk between the immune response 
and lipid metabolism.
MaTerials anD MeThODs
Prediction of mir-31 Targets
The potential targets of miR-31 were predicted by using the 
miRanda v3.01 toolbox by screening of our previous transcriptome 
data (33, 34). The parameters were set as follows: single–residue 
pair scores less than the threshold value of 90 and a minimum free 
energy lower than −17  kcal/mol. Subsequently, the promising 
candidate metabolism-associated genes with the highest scores 
and lowest free energy values was selected as potential targets for 
further analysis.
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animals and challenge experiments
Healthy adult sea cucumbers A. japonicus (weighing 150 ± 15 g) 
were obtained from the Dalian Pacific Aquaculture Company 
(Dalian, China) and acclimatized in 30 L aerated natural seawater 
(salinity 28, temperature 16°C) for 3 days. The pathogen Vibrio 
splendidus was initially isolated from sea cucumbers with SUS 
from the indoor farms of Jinzhou Hatchery in May 2013, preserved 
in glycerol, and stored at −80°C. For the immune challenge, the 
sea cucumbers were randomly divided into five tanks, each con-
taining 10 individuals. Four experimental groups were immersed 
with live V. splendidus at a final concentration of 107 CFU mL−1. 
An identical number of individuals in another tank were kept as 
controls. The coelomic fluids from five individuals were collected 
after exposure for 0, 6, 24, 48, and 72 h and then centrifuged at 
800 g for 5 min to harvest the coelomocytes for the time course 
expression analysis.
cloning and characterization of Full-
length cTrP9 from A. japonicus
The partial sequence of the CTRP9 gene was generated by 
screening the A. japonicus transcriptome database (34). BLASTx 
analysis of the fragment revealed that the sequence contained the 
complete 5’-end compared with that of other reported sequences. 
No polyA tail was detected in the AjCTRP9 fragment. Therefore, 
gene-specific primers for AjCTRP9 (Table S1 in Supplementary 
Material) were designed on the basis of the acquired unigenes, 
and the full-length cDNA sequence was subsequently cloned 
using a 3’-Full RACE Kit (TaKaRa), by following the manufac-
turer’s instructions. The desired PCR products were purified 
and then cloned into the pMD19-T vector. Three positive clones 
for each product were sequenced at Sangon (Shanghai, China). 
Subsequently, the full-length cDNA sequence of AjCTRP9 
was analyzed using the BLAST program at National Center 
for Biotechnology Information1 and the deduced amino acid 
sequence was analyzed with the expert protein analysis system.2 
The signal peptide protein domain features were predicted with 
the Simple Modular Architecture Research Tool.3 The molecular 
mass and theoretical isoelectric point (pI) of the protein were cal-
culated on the basis of the deduced amino acid sequence with the 
ProtParam tool.4 Multiple alignment analysis of each protein was 
performed using the ClustalW2 multiple alignment program.5
3’-UTr luciferase reporter assays
The complete 3’-UTR of wild-type AjCTRP9 containing the 
putative target sites of miR-31 was amplified with gene-specific 
primers (Table S1 in Supplementary Material) to generate frag-
ments and cloned into the pMD19-T simple vector (TaKaRa). 
The putative miRNA binding sites were mutated with a PCR 
approach with mutagenic primers (Table S1 in Supplementary 
Material) and served as the mutant AjCTRP9. The resulting 
clones were then digested with MluI and HindIII and inserted 
1 http://www.ncbi.nlm.nih.gov/blast.
2 http://www.expasy.org/.
3 http://smart.embl-heidelberg.de/.
4 http://www.expasy.ch/tools/protparam.html.
5 http://www.ebi.ac.uk/clustalw/.
into MluI/HindIII-digested pMIR-REPORT luciferase plasmid 
(Promega, USA). These plasmids were sequenced to ensure cor-
rect orientation, and each plasmid was purified with an EZNA™ 
Plasmid Mini Kit (OMEGA, USA). For the transfection experi-
ment, HEK293-T cells were seeded in 96-well plates with 100 μL 
medium and grown to approximately 70% confluence. Then, two 
solutions were added to each well as follows: the first solution 
contained 0.2 μg of pMIR-REPORT with either the wild-type or 
mutated AjCTRP9 3’-UTR and 0.01 μg of pRL-CMV constructs 
(the internal control) with 0.25 μL of the Lipofectamine 2000 
transfection reagent (Invitrogen, USA). The second solution 
contained 100 nM miR-31 mimics (Table S1 in Supplementary 
Material) and 0.25 μL of the transfection reagent. Twenty-five 
microliters of each solution, diluted in the medium, were mixed 
before being added to the wells, and the plates were incubated 
at room temperature for 20  min. Subsequently, the solutions 
were replaced with 50 μL of medium in each well. The cells co-
transfected with 100 nM miR-31 mimics served as the negative 
control (NC) (NCM; Table S1 in Supplementary Material), and 
wild-type or mutated constructs served as the positive control. 
After 48 h of transfection, the cells were prepared for luciferase 
activity assays using a dual-luciferase reporter assay kit (Promega, 
USA). The luciferase signal was expressed as a ratio of firefly to 
Renilla luciferase activities. All of the experiments were per-
formed in six replicates.
Primary coelomocytes culture and lPs 
exposure
Sea cucumbers (weighing 150 ± 15 g) were dissected with steri-
lized scissors on ice, as previously described (35, 36). In brief, the 
coelomic fluids were filtered through a 300-mesh CellCribble to 
remove large tissue debris, mixed with the anticoagulant solution 
(0.02 M EGTA, 0.48 M NaCl, 0.019 M KCl, 0.068 M Tri–HCl, 
pH 7.6) in a 1:1 (V:V) ratio, and then centrifuged at 800 g, 16°C 
for 10 min. The harvested cells were washed twice with isotonic 
buffer (0.001  M EGTA, 0.53  M NaCl, 0.01  M Tris–HCl, pH 
7.6) and resuspended in Leiboviz’s L-15 cell culture medium 
(Invitrogen, USA) containing penicillin (100  U  mL−1) and 
streptomycin sulfate (100 mg mL−1); NaCl (0.39 M) was added 
to adjust the osmotic pressure. The cell suspension was diluted to 
106 cells mL−1 and transferred into 24-well culture microplates and 
incubated at 16°C for 12 h before exposure to lipopolysaccharides 
(Sigma, USA). For the LPS challenge, the cells were stimulated 
with 10 μg mL−1 LPS for 0, 3, 6, 12, and 24 h. The untreated cells 
served as the control. The cells were collected in TRIzol and used 
for expression analysis.
expression analysis of mir-31 and mrnas 
under immune challenge
The expression levels of mRNAs and miR-31 were analyzed using 
a Rotor-Gene 6000 real-time PCR detection system. Total RNA 
was isolated from the coelomocytes using TRIzol (Takara), and 
cDNA was synthesized using a PrimeScript miRNA RT-PCR Kit 
(Takara). The primers used are listed in Table S1 in Supplementary 
Material. RNU6B and Ajβ-actin served as internal controls to nor-
malize the miRNA or the target, respectively, for quantification. 
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Each amplification was carried out in a 20 μL reaction volume 
containing 8 μL of the 1:50 diluted cDNA, 1 μL of each of the 
primers, and 10 μL of SYBR Green Mix (Takara). The reaction 
mixture was incubated for 5 min at 95°C, and this was followed 
by 40 amplification cycles of 15 s at 95°C, 20 s at 60°C, and 20 s 
at 72°C. The 2−ΔΔCT method was used to analyze the relative 
expression levels of both miRNA and mRNA (37), and the values 
obtained denoted the fold difference relative to the calibrator. The 
data are presented as the relative expression levels (mean ± SD, 
n = 5). Differences were considered significant at p < 0.05.
Functional analysis of mir-31 In Vivo
The miR-31 mimics and inhibitor with the 2’-OMe modification 
were synthesized by GenePharma (Shanghai, China) and are 
shown in Table S1 in Supplementary Material. These reagents 
were dissolved in RNase-free water to obtain a 20 μM working 
solution. We mixed 10 μL (2 μM) of miR-31 mimics or inhibitor 
from each working solution with 10 μL of transfection reagent 
and 80 μL of phosphate buffered solution (PBS) at pH 7.6 to serve 
as the transfection solution. Ten sea cucumbers (100 ± 10 g) were 
infected with 100 μL of the above transfection solution. Twenty-
four hours after the injection, the control and treated coelomo-
cytes were collected for further RNA and protein extraction.
silencing of ajcTrP9 In Vivo
Three specific small-interfering RNAs (siRNAs) targeting 
AjCTRP9 with the extra 2’-OMe modification were designed and 
synthesized by GenePharma (Shanghai, China). Another siRNA 
(NC) that did not target any of the genes from the sea cucumber 
transcriptome data served as a NC. The detailed sequences are 
shown in Table S1 in Supplementary Material. Each siRNA and 
the NC siRNA were dissolved in RNase-free water to obtain a 
20 μM working solution. For RNA interference, we mixed 10 μL 
of each siRNA or the NC siRNA with 10 μL of transfection reagent 
and 80 μL of PBS to serve as the transfection solution. Ten sea 
cucumbers (100 ± 10 g) were injected with 100 μL of the trans-
fection solution into the tentacles. Twenty-four hours after the 
injection, the control and treated coelomocytes were collected for 
further RNA, protein, and lipid extraction. AjCTRP9 expression 
was analyzed as described below, and the interference efficiency 
was taken as the average after three siRNA transfections.
ajcTrP9 recombinant Protein expression 
and Polyclonal antibody Preparation
The partial cDNA sequence of AjCTRP9 was cloned with spe-
cific primers (Table S1 in Supplementary Material) then double 
digested with EcoRI and NotI and ligated into the vector pGEX-
4T-2 (GE, USA). Ajβ-actin was used as a control, as described 
in our previous work (38). The recombinant plasmid (pGEX-
4T-2-AjCTRP9) was transformed into Escherichia coli cells of 
Transetta (DE3) (TransGen, China), and the DNA was sequenced 
to ensure correct orientation. The positive transformants were 
subsequently incubated in LB medium containing 50 μg mL−1 of 
ampicillin at 37°C and 200 rpm. Then, the expression of the GST-
tagged fusion protein was induced in pGEX-4T-2-AjCTRP9 with 
1 mM isopropyl-b-d-thiogalactopyranoside (IPTG) at 37°C for 
4 h, and the protein was collected after cells were disrupted with 
ultrasonic waves. The GST-Sefinose™ Resin was used for the 
purification, according to the manufacturer’s protocol (Sangon, 
China). The concentration of the purified soluble protein was 
quantified with a Protein Assay Kit (Sangon, China). The soluble 
target protein, after dialysis, was injected into a 4-week-old 
mouse to acquire polyclonal antibody according to a previously 
described protocol (38).
Western Blot analysis
For the western blot assay, the samples were washed twice in ice-
cold PBS and lysed with lysis buffer (Beyotime Biotechnology, 
China). After lysis, the cells were centrifuged at 10,000  g for 
5 min, the supernatant containing the total protein was collected, 
and the protein concentration was measured using a BCA Protein 
Assay Kit (Sangon, China). Each sample (25 μg) was resolved 
with a 12% SDS-PAGE gel and then transferred to polyvinylidene 
fluoride membranes at 300  mA for 1  h (Millipore, USA) in 
transfer buffer (25 mM Tris, 192 mM Glycine, 20% [v/v] E-OH). 
After being blocked with 5% fat-free dry milk in TBST (25 mM 
Tris–HCl, pH 7.4, 137 mM NaCl, 2.7 mM KCl, 0.1% [v/v] Tween 
20) for 1 h at room temperature, the membranes were incubated 
overnight with AjCTRP9 or Ajβ-actin polyclonal antibodies 
diluted to 1:500 in 5% fat-free dry milk in TBST. The membranes 
were washed three times with TBST and subsequently incubated 
at room temperature for 1  h with goat anti-mouse (Beyotime 
Biotechnology, China) diluted at 1:3,000 in 5% fat-free dry milk 
in TBST. After being washed three times with TBST for 10 min 
each, the membranes were incubated in Western Lightning-ECL 
substrate (Perkin Elmer) before exposure onto X-OMAT AR 
X-Ray films (Eastman Kodak, Rochester, NY, USA).
liquid chromatography and Mass 
spectrometry (lc-Ms) assay after 
ajcTrP9 silencing
After AjCTRP9 silencing, 50 mg of coelomocytes (freeze-dried) 
was extracted in chloroform/methanol/water (1:2:0.8, v/v/v) 
containing 0.05% butylated hydroxytoluene (BHT), according to 
a modified version of the Bligh and Dyer method (39). Briefly, 
the obtained extract was evaporated on a rotary evaporator, 
and the lipid residue was redissolved in 1 mL of methanol after 
centrifugation at 12,000  rpm for 5  min at 4°C. The methanol 
solution of the lipids was filtered with a 0.22 μm ultrafiltration 
membrane (Millipore, USA) to remove the undissolved residues 
and subjected to LC-MS analysis using the previously published 
standard method (40–42).
Chromatographic separations were performed on a Waters 
ACQUITY UPLC system using an ACQUITY UPLC BEH C8 
analytical column (i.d. × l 2.1 × 100 mm, particle size 1.7 μm). 
Briefly, lithium acetate (0.01%) and formic acid (15 mM) were 
added to the mobile phase as the electrolyte for the ESI positive 
mode analysis, and ammonium hydroxide (15 mM) was added 
for the negative ion mode analysis. To obtain efficient separation 
of the total lipids, water/acetonitrile (1:2, v/v) was used as mobile 
phase A, and acetonitrile/isopropyl alcohol/tetrahydrofuran 
(1:1:1, v/v/v) was used as mobile phase B. The mobile phase B 
was changed from 0 to 50% in 15 min, then to 80% in 30 min and 
held for 2 min and finally to the initial 0 in 2 min and equilibrated 
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for 11 min. The temperature of the sample chamber was set at 
4°C, and the injection volume was 5 μL for each analysis. Twenty-
five percent of the flow out of the column was subjected to mass 
spectrometry.
Mass spectrometry was performed on a Waters Q-TOF 
Premier mass spectrometer operating in both positive and nega-
tive ESI modes. The nebulization gas was set to 400 L h−1 at a tem-
perature of 300°C, the cone gas was set to 0 L h−1, and the source 
temperature was set to 120°C. For the ESI+ mode, the capillary 
voltage was set at 3.0 kV and the sampling cone voltage was set 
at 80 V. For the ESI− mode, the capillary voltage was set at 2.5 kV, 
and the sampling cone voltage was set at 60 V. MS2 analysis was 
performed at a collision energy range of 20–40 V. A time-of-flight 
(TOF) analyzer was used in a V mode and tuned for maximum 
resolution (>10,000 resolving power at m/z 1,000). The instru-
ment was previously calibrated with sodium formate, and the lock 
mass spray for precise mass determination was set with leucine-
enkephalin, thus generating an [M + H]+ ion at 556.2771 Da and 
an [M − H]− ion at 554.2615 Da in the ESI+ mode and ESI− mode, 
respectively. The lock spray frequency was set at 10 s.
The raw data files obtained from ultra-performance liquid 
chromatography-quadrupole time-of-flight mass spectrometry 
runs were analyzed using a MassLynx 4.1 data processing system 
(Waters, Milford, MA, USA). The resulting multivariate dataset 
consisting of the peak number (based on the retention time 
and m/z), sample name, and the normalized peak intensity was 
exported and analyzed with principal component analysis (PCA), 
the projection to latent structures was analyzed with discriminant 
analysis (PLS-DA), and the orthogonal projection to latent struc-
tures was analyzed with discriminant analysis (OPLS-DA) using 
SIMCA-P-12.0 software (Umetrics, Sweden). The loading scatter 
S-plots and contribution lists were used to describe the candidate 
markers that were significantly different between the two groups. 
One-way analysis of variance (ANOVA) was conducted on the A. 
japonicus between the NC and siAjCTRP9 groups to determine 
the statistical significance (p < 0.05) of the candidate markers.
cell-Permeable c6 cer Treatment
C6 Cer (Biomol, USA), short for C6 Cer, was dissolved in 
anhydrous DMSO to obtain 5  mg  mL−1 C6 Cer stock solution. 
For Cer treatment, 10 sea cucumbers (100 ± 10 g) were injected 
with 100 μL of Cer at the concentration of 100 μg mL−1. The sea 
cucumbers in the control group were given an injection of 100 μL 
diluted DMSO. Twenty-four hours after the injection, the treated 
and control coelomocytes were collected for further expression 
analysis.
Determination of apoptosis by Flow 
cytometry assay (Facs)
In vivo cell apoptosis rates were determined by flow cytom-
etry. The sea cucumbers were injected with miR-31 mimics, 
miR-31-inhibitor, AjCTRP9 siRNA, and C6 Cer, as described 
above. The apoptosis rates of the coelomocytes were measured 
with an Annexin V-FITC Apoptosis Detection Kit (Beyotime 
Biotechnology, China). For Annexin V/PI staining, the collected 
coelomocytes were resuspended in 200  μL Annexin V-FITC 
binding buffer and 5 μL Annexin V-FITC and 10 μL PI were 
successively added to 105 cells. Finally, the apoptosis rates were 
detected with a FACScan (BD, USA) after 10 min incubation in 
the dark at room temperature.
Measurement of caspase activity
Caspase-3/8 activity assays were performed using a Caspase 
Activity Assay Kit (Beyotime Biotechnology, China). Briefly, 
the samples were lysed with lysis buffer for 15 min on ice. Then, 
the cells were centrifuged at 16,000 g for 20 min at 4°C, and the 
supernatant was immediately used for caspase-3/8 enzyme assays. 
Caspase activity was measured through the cleavage of a color-
less substrate Ac-DEVD-pNA for caspase-3 and Ac-IETD-pNA 
for caspase-8, thus releasing pNA (p-nitroaniline). Absorbance 
was measured at OD405  nm using a microplate reader (Thermo 
Scientific). The protein concentration of the cells was measured 
using a Bradford Protein Assay Kit (Beyotime Biotechnology, 
China). Caspases-3/8 activities were calculated using a standard 
curve. One unit was defined as the amount of enzyme cleaving 
1.0  nmol of the colorimetric substrate pNA per hour at 37°C 
under saturated substrate concentrations. The assays described 
above were repeated five times.
statistical analysis
All experiments were performed in biological replicates. Data 
are presented as the mean ± SD. The statistical significance was 
determined by one-way ANOVA followed by Duncan’s multiple 
range tests to determine the differences in the mean values as 
compared with the controls. The criterion for significance of the 
difference between means was p < 0.05.
resUlTs
Target identification of mir-31
On the basis of the transcriptome data of sea cucumber A. 
japonicus (33, 34), the target of miR-31 was bioinformatically 
predicted by the miRanda v3.01 toolbox. Information on the 
binding sites of miR-31 in the 3’-UTR of AjCTRP9 and the 
mutated sites is shown in Figure 1A. Imperfect pairing with a GU 
mismatch was allowed in many instances (43–45). To verify the 
prediction, we performed dual-luciferase reporter assays in HEK-
293T cells transfected with miR-31 or control mimics together 
with the luciferase reporter plasmids containing either the 
AjCTRP9 3’-UTR WT or the AjCTRP9 3’-UTR MT (Figure 1B). 
Overexpression of miR-31, compared with the control mimics, 
significantly decreased the level of luciferase activity containing 
the entire 3’-UTR by 33.38% (p < 0.0001), and the results were 
not significantly different for transfection with the mutant vector, 
thus indicating that the AjCTRP9 gene may be a target of miR-31.
cloning and sequence analysis  
of ajcTrP9
The full-length cDNA of AjCTRP9 was generated by overlapping 
original fragments from ESTs and using a 3’-RACE approach in 
the sea cucumber A. japonicus and was deposited in GenBank 
under accession number KX50326. The cDNA sequence of 
AjCTRP9 was 1,718 bp in length and contained a 909 bp ORF 
encoding a predicted product with 302 amino acid residues with a 
FigUre 1 | identification and characterization of the mir-31 binding 
sites in the 3’-untranslated region (3’-UTr) of AjCTRP9. (a) Schematic 
representation of putative miR-31 binding sites in the AjCTRP9 3’-UTR and 
the mutant sites (the protein domain of AjCTRP9 was annotated with SMART 
at http://smart.embl.de/), the red letters represent “seed” regions.  
(B) AjCTRP9 luciferase reporter assays conducted in HEK-293T cells 
carrying the wild-type AjCTRP9 3’-UTR and a mutant AjCTRP9 3’-UTR (final 
concentration: 100 nM).
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molecular weight of 32.37 kDa and a theoretical pI of 5.37 (Figure 
S1 in Supplementary Material). Smart analysis showed that the 
deduced amino acid sequence of AjCTRP9 contains a short 
N-terminal signal peptides (residues 1–23), a short variable region 
(residues 25–43), a collagen domain with 34 “Gly-X-Y” repeats 
(residues 45–155), and an a-terminal globular domain that is 
homologous to c1q domain immune complement component 1q 
(C1q) (residues 161–299) (Figure 1A; Figure S1 in Supplementary 
Material). There were a total of nine proline residues at the third 
position (Gly-X-Pro) within the collagen domain, which is often 
hydroxylated to enhance the stability of the collagen triple-helical 
structure (46). In addition, its collagen domain also had three 
conserved lysine residues that conformed to the consensus 
sequence (Gly-X-Lys), which can potentially be hydroxylated 
and glycosylated. Furthermore, multiple alignments indicated 
that AjCTRP9 shares 47.3% homology with Saccoglossus kowa-
levskii CTRP9 (XP_002739445.1), 44.0% homology with Homo 
sapiens CTRP9 (AAH40438.1), and 40.9% homology with Danio 
rerio CTRP9 (XP_005162770.1). Because a short N-terminal 
variable region was present in the CTRP9 from invertebrates and 
had the lowest similarity to CTRP9 from vertebrates, we 
speculated that the evolution of invertebrate CTRP9 may have 
been earlier than that of the other CTRP9 members (Figure S2 in 
Supplementary Material).
expression analysis of ajcTrP9 and 
mir-31 in immunity
The temporal expression levels of miR-31 and AjCTRP9 in 
coelomocytes post V. splendidus challenge and LPS treatment 
are shown in Figure 2. After the challenge with V. splendidus, 
the level of miR-31 significantly increased by 1.41-fold (p < 0.05) 
during the first 6  h, as compared with the control group and 
reached peak expression at 24 h with 1.85-fold (p < 0.01) increase 
(Figure  2A). Additionally, after exposure to 10 μg  mL−1 LPS, 
the level of miR-31 sharply increased by 1.65-fold, as compared 
with the control (p < 0.01) during the first 6 h, and the elevated 
expression was maintained until 24  h (Figure  2B). However, 
the AjCTRP9 transcript showed an opposite expression trend 
from that of miR-31 in response to both V. splendidus challenge 
and LPS treatment (Figure  2). The transcription of AjCTRP9 
was gradually downregulated and exhibited the least expres-
sion at 72  h, with a 0.49-fold (p <  0.01) decrease after the V. 
splendidus challenge (Figure 2A). The minimal expression level 
of AjCTRP9 after the LPS stimulation was detected at 24 h, with 
a 0.29-fold (p < 0.01) decrease compared with the control group 
(Figure 2B).
loss- and gain-of-Function assay  
of mir-31
To further elucidate the functional roles of miR-31 in regulating 
AjCTRP9, loss-of-function or gain-of-function assays of miR-31 
were performed in vivo. As shown in Figure 3, quantitative PCR 
indicated that the overexpression of miR-31 (Figure 3A) signifi-
cantly decreased the mRNA expression of AjCTRP9 by 0.46-fold 
(p <  0.05) (Figure  3B). Accordingly, the inhibition of miR-31 
(Figure  3C) resulted in the elevated expression of AjCTRP9 
by 1.65-fold (p  <  0.05) (Figure  3D). Furthermore, western 
blot analysis of the aberrant expression of miR-31 revealed 
that the protein abundance of AjCTRP9 was decreased after 
miR-31 overexpression and increased after miR-31 inhibition 
(Figure 3E), in agreement with the AjCTRP9 mRNA expression 
levels. Our results indicated that miR-31 directly targeted the 
AjCTRP9 gene.
lipidomic analyses of A. japonicus 
coelomocytes after sirna-Mediated 
ajcTrP9 silencing
From the above results, we observed that miR-31 directly targets 
the AjCTRP9 gene. As a CTRP family member, CTRP9 plays 
important roles in multiple physiological processes, especially in 
fatty acid oxidation (47). To further investigate the possible bio-
logical roles of the AjCTRP9, the lipidomics of coelomocytes were 
analyzed by LC-MS after AjCTRP9 silencing. Figure 4 shows the 
expression levels of AjCTRP9 after specific siRNA transfection. 
Our results showed that the injection of AjCTRP9 siRNA specifi-
cally inhibited AjCTRP9 transcript expression (Figure 4A) and 
protein expression (Figure  4B) in  vivo. Therefore, the changes 
FigUre 2 | The time course of expression patterns of mir-31 and AjCTRP9. (a) AjCTRP9 mRNA transcripts and miR-31 expression in Vibrio splendidus-
challenged Apostichopus japonicus. (B) AjCTRP9 mRNA transcripts and miR-31 expression in LPS-treated coelomocytes. Values are given as the mean ± SD, 
n = 5. Asterisks indicate significant differences: *p < 0.05, **p < 0.01.
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in the lipid metabolites of coelomocytes were identified in the 
siAjCTRP9 and NC groups.
The samples were characterized by LC-MS in both positive 
and negative ion mode. The mass spectral data were processed by 
multivariate analysis. The PCA score plots (Figure 5) in both ion 
modes showed that the two samples of A. japonicus were clearly 
separated by the first components. A trend of time-dependent 
cluster formation by the first two components was observed in 
both ESI+ and ESI− modes, thus explaining 58.1% (Figure 5A) 
and 62.8% (Figure  5B) of the all variances, respectively. The 
OPLS-DA score plot showed significant lipidomic differences 
between the siAjCTRP9 and NC groups (Figure 6). As shown in 
the positive ion mode (Figure 6A), the parameters R2X, R2Y, and 
Q2 revealed the high discriminative and predictive ability of the 
model. Further model validations in PLS-DA, with the number 
of permutations equal to 200, generated intercepts of R2 = 0.372 
and Q2 = −0.178 (Figure  6B). Along with those obtained in 
negative mode (Figures 6C,D), these results demonstrated that 
the OPLS-DA models were well fitting and statistically valid. 
The S-plot visualizes the covariance and correlation among the 
metabolites, and thus can be used to identify important metabo-
lites (48). The significant metabolites at the top and bottom of 
the S-plots (Figure 7) were related to the group separation and 
were selected as potential biomarkers (Table  1) according to 
parameters of variable importance in the projection (VIP). The 
relative abundance of significant ions that were higher in the 
siAjCTRP9 group compared with the NC group in sea cucumber 
were located in the upper-right quadrant (with >0 of correlation) 
of the S-plot after the OPLS-DA approach (Figure 7), including 
seven phosphatidylcholines (PC) (18:1/18:2; 18:2/17:1; 18:1/18:1; 
15:0/18:2; 20:1/18:2; 15:0/20:2; 18:2/18:2), three Cers (d15:1/20:0; 
d15:1/21:0; d17:1/23:1), and TAG (16:0/16:0/16:0), whereas those 
that were lower in abundance were in the lower-left quadrant 
(with <0 of correlation), including four PC (17:1/20:5; 17:1/20:4; 
15:0/20:5; 22:6/13:0), two phosphatidylethanolamine (PE) 
(17:1/20:4; 18:1/20:5), two lysophosphatidylcholine (LPE) (20:5; 
20:4), three TAG (18:1/18:1/16:0; 18:1/18:1/16:1; 18:1/16:0/20:2), 
and (LPC) (18:2).
ajcTrP9 Knockdown induces 
accumulation of cer Mass Mainly through 
sphingosine Metabolism
According to significantly different metabolites (Table  1), 
we found that the three identified Cer species (d15:1/20:0; 
d15:1/21:0; d17:1/23:1) were dramatically increased by 3.68-, 
4.97-, and 1.22-fold after AjCTRP9 interference, respectively. Cer 
is a condensation product of the amino alcohol sphingosine and 
a fatty acid during an acylation reaction. It is a key intermediate 
in sphingolipid metabolism and an important signaling molecule 
in determining cell fate (49). To understand which biological 
process resulted in the Cer accumulation after AjCTRP9 deletion, 
we investigated the fluctuations in expression of Cer metabolism-
related genes by qPCR (Figure  8A). As shown in Figure  8A, 
the expression levels of Cer synthase 1 and Cer synthase 6 were 
significantly increased by 1.44-fold (p  <  0.05) and 1.66-fold 
(p < 0.01) after AjCTRP9 silencing, respectively, whereas the Cer 
synthase 5 transcript was downregulated by 0.69-fold (p < 0.05). 
In addition, the mRNA levels of neutral ceramidase 1 and puta-
tive neutral sphingomyelinase both sharply decreased by 0.35-fold 
(p < 0.01) and 0.57-fold (p < 0.05), respectively, after interference. 
There were no significant changes in serine palmitoyltransferase 
(SPT) 1 and SPT 2 transcripts after AjCTRP9 knockdown. These 
results revealed that the increase in the three Cer contents might 
have represented the Cer synthases after silencing of AjCTRP9, in 
which different Cer synthases N-acylated sphingosine to form the 
different Cers.
c6 cer exposure increases sPT mrna 
expression and Directly Promotes cell 
apoptosis
To explore the functional effect of Cer on cell survival, we meas-
ured cell apoptosis after Cer treatment of A. japonicus in  vivo 
(Figure 9). In response to the stimulation with 100 μg mL−1 Cer, 
the apoptosis rate was sharply increased by 1.80-fold (p < 0.01) 
compared with the control (Figures 9A1–A3), thus showing that 
the disturbance in Cer signaling directly induced cell death in 
FigUre 3 | Functional analysis of mir-31 and AjCTRP9 in vivo.  
(a) Relative miR-31 expression level after transfection with modified 
microRNA (miRNA) mimics. (B) Relative expression level of AjCTRP9 after 
transfection with modified miRNA mimics. (c) Relative miR-31 expression 
level after transfection with modified miRNA inhibitor. (D) Relative expression 
level of AjCTRP9 after transfection with modified miRNA mimics. (e) Western 
blot analysis of AjCTRPP protein after transfection with modified miRNA 
mimics or inhibitor. Values are given as the mean ± SD, n = 5. Asterisks 
indicate significant differences: *p < 0.05, **p < 0.01.
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A. japonicus. In addition, we found that the mRNA expression 
profiles of SPT 1, SPT 2, Cer synthase 1, and Cer synthase 6 were 
upregulated by 2.86-fold (p < 0.01), 2.28-fold (p < 0.01), 1.46-
fold (p < 0.05), and 1.77-fold (p < 0.05), respectively, after the 
exposure to exogenous Cer (Figure 8B). In contrast, the neutral 
ceramidase 1 transcript was decreased by 0.56-fold (p <  0.05) 
compared with the control, thus indicating that the overexpres-
sion of short Cer might lead to the enrichment of longer Cers in 
A. japonicus cells through a de novo synthesis pathway by SPT 
and that the exposure of exogenous Cer disturbs the sphingolipid 
metabolism in sea cucumber.
mir-31 regulates apoptosis in  
A. japonicus coelomocytes by  
Targeting ajcTrP9
To test the hypothesis that miR-31 regulates apoptosis in A. 
japonicus by targeting AjCTRP9, we further investigated the 
apoptosis of cells transfected with a series of reagents in  vivo 
(Figure  9). Transfection with miR-31 mimics significantly 
induced cell apoptosis (1.35-fold, p < 0.05) 24 h post infection 
(Figures  9C1–C3). Downregulation of AjCTRP9 with specific 
siRNA also induced apoptosis (1.51-fold, p <  0.05) under the 
same conditions (Figures 9D1–D3).
mir-31 Targeting ajcTrP9 Modulates cer 
content and induces apoptosis through 
caspase cascades
From the results above, we concluded that miR-31 regulates 
apoptosis by targeting AjCTRP9 in A. japonicus through the 
overproduction of Cer. To reveal the molecular cascade of 
apoptosis regulated by signaling of Cer channels, we first 
examined the expression of apoptotic genes after Cer injection 
(50) (Figure 10A). We noticed that caspase-3 and caspase-8 tran-
scripts were both markedly upregulated by 1.35-fold (p < 0.05) 
and 2.42-fold (p < 0.01), respectively, compared with the control, 
thus indicating that these two molecules play key roles in Cer-
induced apoptosis. To accurately evaluate the caspase cascades, 
the enzymatic activities of caspases were measured from the 
coelomocytes after transfection with a series of reagents in vivo 
(Figures  10B,C). As shown in Figure  10B, caspase-8 activity 
was significantly induced after miR-31 overexpression, AjCTRP9 
silencing, and Cer exposure. The caspase-3 activity was also 
consistent with caspase-8 activity in every condition and had a 
greater magnitude after AjCTRP9 knockdown, thus suggesting 
that caspase-8 directly modulates caspase-3 and promotes apop-
tosis. The regulatory interplay among miR-31, AjCTRP9, Cer, and 
apoptosis is diagrammed in Figure 11.
DiscUssiOn
microRNAs are powerful regulators of gene expression under 
normal physiological processes or in pathological states (51). 
In our previous work, we have revealed that miR-31 modulates 
respiratory burst by targeting NF-κB (p105) during pathological 
development in sea cucumbers (52). Currently, accumulating 
evidence suggests that miRNAs are key players in the regulation 
of inflammation and metabolism (16, 53). A given miRNA may 
have multiple mRNA targets that are involved in nearly every 
biological process (54). miR-31 belongs to a highly evolutionarily 
conserved miRNA “seed family” that participates in the immune 
response, and whose abnormal expression or function in the 
immune system has been linked to multiple diseases (55–57). 
However, the limitations of these studies restrict the extrapola-
tion to effects on immune defense and cell homeostasis after 
host–pathogen interactions. In the current study, we discovered 
a novel role of miR-31 in promoting cell apoptosis in A. japonicus 
by targeting AjCTRP9, which encodes an important adipokine 
involved in multiple physiological processes. The most salient 
finding of this paper is the identification of the role of miR-31 in 
regulating lipid-mediated signal transduction events during the 
interactions between bacterial pathogens and host cells.
Metabolism and immunity are often liked by proteins of dual 
function. CTRP9, a member of the CTRP family, has attracted 
much interest because of its anti-inflammatory and metabolic 
effects, especially in glucose metabolism and fatty acid oxidation 
FigUre 5 | Principal component analysis score scatter plot in esi+ (a) and esi− (B) mode for the total lipids of Apostichopus japonicus between the 
siajcTrP9 group (green) and the negative control group (blue).
FigUre 4 | The expression level of ajcTrP9 after transfection with specific small-interfering rnas (sirnas). (a) Relative expression level of AjCTRP9 
after AjCTRP9 siRNA transfection. (B) Western blot analysis of AjCTRPP protein after AjCTRP9 siRNA transfection. Values are given as the mean ± SD, n = 5. 
Asterisks indicate significant differences: *p < 0.05, **p < 0.01.
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(46, 58). In the present study, we found that the mRNA level 
of AjCTRP9 was significantly decreased and showed opposite 
expression trends from those of miR-31 after V. splendidus chal-
lenge and LPS exposure in primary coelomocytes (Figure  2). 
Moreover, our results showed that the overexpression of miR-
31 or silencing of AjCTRP9 in  vivo resulted in an increase in 
the apoptotic rates (Figure  9), thus suggesting that miR-31 
negatively targets AjCTRP9 and induces cell apoptosis during 
the immune response. However, the apoptosis rate was not 
significantly changed after transfection with the miR-31 inhibi-
tor (Figures 9B1–B3). In humans, CTRP9 levels are negatively 
associated with the amount of visceral fat and are positively 
associated with a favorable glucose or metabolic phenotype (31, 
59). When overexpressed, CTRP9 significantly ameliorates pal-
mitate- or tunicamycin-induced hepatic steatosis and apoptosis 
(60). Additionally, CTRP9 protects against acute cardiac damage 
in response to pathological stimuli by suppressing inflammatory 
reactions through adiponectin receptors (61). However, targeted 
deletion of CTRP9 increases food intake, decreases insulin 
sensitivity, and promotes hepatic steatosis in mice (58). These 
studies have clearly demonstrated that CTRP9 plays pivotal roles 
in modulating metabolism during inflammation. More impor-
tantly, the complementary gain-of-function and loss-of-function 
results support a role for CTRP9 in regulating lipid metabolism. 
In addition, our previous data obtained from high-throughput 
sequencing have revealed that the AjCTRP9 transcript is sharply 
downregulated after miR-31 overexpression, and significant 
metabolic differences are also present in sea cucumbers with 
SUS (29, 30). On the basis of these results, we speculate that the 
abnormal expression of miR-31 targeting the AjCTRP9-induced 
apoptosis might perturb the lipid balance in the cells and may 
have contributed to SUS outbreaks in A. japonicus.
To explore the miR-31-mediated apoptosis resulting from per-
turbed cell lipid metabolism, we further investigated the lipidom-
ics of coelomocytes analyzed by LC-MS after AjCTRP9 silencing. 
The results indicated remarkable differences in lipid profiles of the 
two groups (Figures 5–7), and some lipid molecules including 
PC, LPC, TAG, PE, LPE, and Cer were significantly increased or 
decreased after AjCTRP9 knockdown (Table 1). These lipids have 
previously been shown to have multiple critical roles in cellular 
functions, such as cell growth, signal transduction, membrane 
homeostasis, and apoptosis (5, 62, 63). From these results, we 
FigUre 7 | OPls loading s-plot for the total lipids of the siajcTrP9 group and the negative control group detected in the esi+ (a) and esi− (B) 
modes. Significant ions are outlined in red and listed in Table 1.
FigUre 6 | scatter plot of OPls-Da scores (a,c) and validation plot (B,D) of the Pls-Da analysis on siajcTrP9 group in both positive (a,B) and 
negative (c,D) ion scan modes compared with the negative control group.
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concluded that the miR-31-targeted modulation of AjCTRP9 
expression may be an extremely important mechanism in lipid 
metabolism. Notably, three types of identified Cers (d15:1/20:0; 
d15:1/21:0; d17:1/23:1) were synchronously increased after 
AjCTRP9 interference, thus indicating that the Cer species might 
be promising biomarkers for lipid metabolism imbalance. Cers 
are important intermediators of sphingolipid metabolism and 
function not only as structural components of cell membranes 
but also as key mediators of apoptosis triggered by various 
stimuli in most cells (64, 65). Accumulating evidence indicates 
that excessive levels of Cer directly promote cell apoptosis (66, 
67). In this study, we also observed that the apoptosis rate was 
significantly increased after Cer exposure (Figure  9). Hence, 
we confirmed that the downregulation of AjCTRP9 by miR-31 
mainly results in the production of Cers and further induces 
apoptosis in coelomocytes. Cers are mainly produced from the 
de novo synthesis pathway regulated by the enzyme SPT (68, 
69). Alternatively, they can also be generated by the sphin-
gosine salvage pathway through the action of Cer synthases or 
the reverse activity of neutral ceramidase (70). Ogretmen et al. 
have determined that exogenous short-chain C6 Cer induces the 
production of endogenous long-chain Cer in the A549 human 
adenocarcinoma cell line through the recycling of the sphingosine 
backbone (71). Grether-Beck et al. have reported that stimulation 
FigUre 8 | The mrna expression levels of relative genes after AjCTRP9 silencing (a) and cer treatment (B). Values are given as the mean ± SD, n = 5. 
Asterisks indicate significant differences: *p < 0.05, **p < 0.01.
TaBle 1 | summary of the metabolite ions of Apostichopus japonicus that showed significant changes between the siajcTrP9 and negative control 
groups.
rT (min) m/z annotation cov cor Variable importance in the projection Fold changes
8.17 798.5 [M + Li]+ 17:1/20:5-PC −0.205713 −0.732526 8.16913 0.72
8.51 784.5 [M + H]+ 18:1/18:2-PC 0.160094 0.578532 6.35124 3.66
8.99 770.5 [M + H]+ 18:2/17:1-PC 0.151788 0.490732 6.02605 1.42
9.41 786.5 [M + H]+ 18:1/18:1-PC 0.139849 0.59799 5.54959 3.98
8.97 800.5 [M + Li]+ 17:1/20:4-PC −0.117883 −0.503678 4.67847 0.76
8.83 744.5 [M + H]+ 15:0/18:2-PC 0.113798 0.558261 4.51796 1.79
10.65 842.5 Unknown −0.106533 −0.774079 4.22787 0.68
8.01 772.5 [M + Li]+ 15:0/20:5-PC −0.103263 −0.735489 4.09839 0.67
9.96 558.5 [M + Li]+ d15:1/20:0-Cer 0.0973946 0.768276 3.86752 3.68
10.66 572.5 [M + Li]+ d15:1/21:0-Cer 0.0937542 0.782561 3.72185 4.97
1.92 464.3 [M-H]− 20:5-LPE −0.122912 −0.502297 3.64418 0.76
9.61 812.5 [M + H]+ 20:1/18:2-PC 0.0910315 0.669488 3.61434 5.20
12.08 626.5 [M + Li]+ d17:1/23:1-Cer 0.0880302 0.706791 3.49483 1.22
3.87 339.2 Unknown −0.116787 −0.562221 3.47243 0.75
10.04 772.5 [M + H]+ 15:0/20:2-PC 0.0796566 0.502002 3.15563 4.21
1.85 466.3 [M-H]− 20:4-LPE −0.106769 −0.801495 3.14981 0.55
18.64 865.7 [M + Li]+ 18:1/18:1/16:0-TAG −0.0676901 −0.780218 2.68574 0.32
18.1 863.7 [M + Li]+ 18:1/18:1/16:1-TAG −0.0673214 −0.824131 2.67018 0.22
7.14 770.5 [M + Li]+ 22:6/13:0-PC −0.0659779 −0.799264 2.61918 0.75
7.7 782.5 [M + H]+ 18:2/18:2-PC 0.065864 0.56148 2.6143 2.76
18.56 813.7 [M + Li]+ 16:0/16:0/16:0-TAG 0.0621351 0.674626 2.4658 2.23
11.27 802.5 Unknown −0.0613742 −0.530681 2.43706 0.80
18.7 891.7 [M + Li]+ 18:1/16:0/20:2-TAG −0.0608799 −0.805357 2.41512 0.23
1.37 492.3 [M-CH3]− 18:2-LPC −0.0555527 −0.560026 1.6503 0.58
10.33 750.5 [M-H]− 17:1/20:4-PE −0.0552554 −0.363959 1.63801 0.96
10.08 762.5 [M-H]− 18:1/20:5-PE −0.0460899 −0.551591 1.37487 0.66
Ion ranks from the loading S-plot of OPLS-DA analysis showed the rank of ions with the highest confidence and greatest contribution to the separation between the siCTRP9 and 
NC groups. The ion rank is synonymous to labeling the ions with relevant m/z as in Figure 7. Cov. (covariance), Cor. (correlation), and VIP were obtained from the OPLS-DA analysis 
by using the datasets from positive or negative ion scan modes to determine the ESI+ and ESI− corresponding to the positive and negative ions of the relevant adducts, respectively. 
Fold change equals the peak area observed in the siAjCTRP9 group compared with the NC group.
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of keratinocytes with exogenous C6 Cer induces de novo Cer syn-
thesis in human keratinocytes through the induction and activa-
tion of the SPT mRNA (72). In our case, there were no significant 
changes in the SPT transcript after silencing AjCTRP9, but its 
mRNA expression was markedly increased after Cer injection 
(Figure 8), thus indicating that treatment with short Cers might 
result in the synthesis of longer Cers. In addition, sphingomyelin 
or sphingosine hydrolysis in cell membranes also contributes to 
the production of Cers by different metabolic enzymes (69). We 
found that the mRNA levels of Cer synthase 1 and Cer synthase 
6 were both notably upregulated, whereas neutral ceramidase 
1 and putative neutral sphingomyelinase transcripts were both 
FigUre 9 | The apoptosis rate of Apostichopus japonicus coelomocytes. (a-1–a-3) Cer treatment; (B-1–B-3) miR-31 inhibition; (c-1–c-3) miR-31 
overexpression; (D-1–D-3) AjCTRP9 silencing. Values are given as the mean ± SD, n = 5. Asterisks indicate significant differences: *p < 0.05, **p < 0.01.
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FigUre 10 | effects of cer treatment on caspase activity in the coelomocytes of Apostichopus japonicus. (a) The mRNA expression level of 
caspase-3/-6/-8; (B) caspase-8 activity; (c) caspase-3 activity. Values are given as the mean ± SD, n = 5. Asterisks indicate significant differences: *p < 0.05, 
**p < 0.01.
FigUre 11 | schematic representation of the involvement of mir-31 
in disturbing the lipid metabolism balance by targeting AjCTRP9.
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significantly downregulated after AjCTRP9 knockdown. Clearly, 
the overproduction of Cers after AjCTRP9 interference occurs 
mainly as a result of sphingosine hydrolysis. Moreover, Cer syn-
thase 1, Cer synthase 6, and neutral ceramidase 1 transcript levels 
after Cer challenge displayed almost identical expression profiles 
with the levels after silencing AjCTRP9. A study by Osawa et al. 
has indicated that the dynamic balance between the intracellular 
levels of Cers and sphingosine may determine cell survival (73). 
Hence, the aberrant expressions of metabolic enzymes regulate 
Cer channel formation and induce cell apoptosis. Our present 
findings indicated that miR-31 negatively modulates the expres-
sion of AjCTRP9 and the disturbance in Cer channels, thereby 
initiating apoptosis. Apoptosis is a very complex multistep process 
dependent on several apoptosis-related molecules, but its signal-
ing is triggered by either the extrinsic pathway or the intrinsic 
pathway (74). The primary regulators of apoptosis are a family of 
cysteine-aspartic specific proteases known as caspases (75). Our 
results showed that the levels of caspase-3 and caspase-8 mRNAs 
were significantly induced after Cer treatment (Figure  10A). 
Furthermore, the enzymatic activities of the initiator caspase-8 
and the executioner caspase-3 were both clearly upregulated 
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after miR-31 overexpression and AjCTRP9 silencing, as well as 
exogenous Cer exposure (Figures 10B,C), thus suggesting that 
the sequential activation of caspases plays critical roles in the final 
steps of apoptosis.
In summary, the present study provides novel evidence that 
miR-31 plays a key role in Cer channel formation by targeting 
AjCTRP9, thereby linking immune defense with lipid metabolism 
(Figure  11). miR-31, a highly conserved and multifunctional 
regulator that negatively targets AjCTRP9 and disturbs the lipid 
metabolism balance, further results in Cer channel formation, 
thus ultimately leading to cell apoptosis during host–pathogen 
interactions. These new findings may provide new therapeutic 
perspectives with which to suppress miR-31 expression in sea 
cucumbers with SUS.
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